These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31944310)

  • 1. Sumatriptan Does Not Antagonize CGRP-Induced Symptoms in Healthy Volunteers.
    Falkenberg K; Rønde Bjerg H; Yamani N; Olesen J
    Headache; 2020 Apr; 60(4):665-676. PubMed ID: 31944310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-Hour CGRP Infusion Causes Gastrointestinal Hyperactivity: Possible Relevance for CGRP Antibody Treatment.
    Falkenberg K; Bjerg HR; Olesen J
    Headache; 2020 May; 60(5):929-937. PubMed ID: 32227602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a pragmatic human migraine model for drug testing: 2. Isosorbide-5-mononitrate in healthy individuals.
    Hansen EK; Olesen J
    Cephalalgia; 2017 Jan; 37(1):11-19. PubMed ID: 26924839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a pragmatic migraine model for drug testing: I. Cilostazol in healthy volunteers.
    Hansen EK; Guo S; Ashina M; Olesen J
    Cephalalgia; 2016 Feb; 36(2):172-8. PubMed ID: 25934317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous sumatriptan reduces cilostazol induced headache in migraine patients.
    Falkenberg K; Bjerg HR; Olesen J
    Cephalalgia; 2020 Jul; 40(8):842-850. PubMed ID: 32216457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
    Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M
    JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
    Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
    Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol induced migraine does not respond to sumatriptan in a double blind trial.
    Falkenberg K; Dunga BÓÁ; Guo S; Ashina M; Olesen J
    J Headache Pain; 2018 Feb; 19(1):11. PubMed ID: 29396788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers.
    Falkenberg K; Olesen J
    J Headache Pain; 2018 Aug; 19(1):71. PubMed ID: 30120600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers.
    Asghar MS; Hansen AE; Kapijimpanga T; van der Geest RJ; van der Koning P; Larsson HB; Olesen J; Ashina M
    Neurology; 2010 Oct; 75(17):1520-6. PubMed ID: 20975053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure in healthy volunteers.
    de Hoon J; Van Hecken A; Vandermeulen C; Herbots M; Kubo Y; Lee E; Eisele O; Vargas G; Gabriel K
    Cephalalgia; 2019 Jan; 39(1):100-110. PubMed ID: 29783863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
    Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
    Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migraine induction with calcitonin gene-related peptide in patients from erenumab trials.
    Christensen CE; Younis S; Deen M; Khan S; Ghanizada H; Ashina M
    J Headache Pain; 2018 Nov; 19(1):105. PubMed ID: 30409109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CGRP and sumatriptan on the BOLD response in visual cortex.
    Asghar MS; Hansen AE; Larsson HB; Olesen J; Ashina M
    J Headache Pain; 2012 Mar; 13(2):159-66. PubMed ID: 22246026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Trial of Ketorolac vs. Sumatripan vs. Placebo Nasal Spray (KSPN) for Acute Migraine.
    Rao AS; Gelaye B; Kurth T; Dash PD; Nitchie H; Peterlin BL
    Headache; 2016 Feb; 56(2):331-40. PubMed ID: 26840902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the prototype serotonin 5-HT(1B/1D) receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) on myocardial reactive hyperemic response in conscious dogs.
    Lynch JJ; Shen YT; Pittman TJ; Anderson KD; Koblan KS; Gould RJ; Regan CP; Kane SA
    Eur J Pharmacol; 2009 Nov; 623(1-3):96-102. PubMed ID: 19766109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glyceryl trinitrate and calcitonin gene-related peptide on BOLD signal and arterial diameter: methodological studies by fMRI and MRA.
    Asghar MS
    Dan Med J; 2012 Jul; 59(7):B4489. PubMed ID: 22759854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial.
    Asadollahi S; Heidari K; Vafaee R; Forouzanfar MM; Amini A; Shahrami A
    Headache; 2014 Jan; 54(1):94-108. PubMed ID: 24182419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache.
    Ghanizada H; Al-Karagholi MA; Arngrim N; Mørch-Rasmussen M; Metcalf-Clausen M; Larsson HBW; Amin FM; Ashina M
    J Headache Pain; 2020 Feb; 21(1):19. PubMed ID: 32093617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consistency of response to sumatriptan/naproxen sodium in a randomized placebo-controlled, cross-over study for the acute treatment of migraine in adolescence.
    Winner P; Linder S; Hershey AD
    Headache; 2015 Apr; 55(4):519-28. PubMed ID: 25881677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.